Biospace med, based in Paris, announced today that it has received clearance from the Food and Drug Administration to market the company’s EOS x-ray imager along with its new image workstation, sterEOS, which enables 3D skeletal reconstruction.

EOS is ideal for such clinical indications as spine pathologies and hip and knee arthropathies, where a weight-bearing assessment is necessary to ensure optimal treatment.

The technology can capture head-to-toe images of patients in a standing, weight-bearing position with up to 10 times less radiation dosage than a conventional x-ray and up to 1000 times less than a CT scan.

Additionally, the new sterEOS 3D reconstruction and measurement workstation is designed to reduce surgical planning time and help establish the most effective course of treatment.